Semax (10mg)

BDNF-Upregulating Nootropic Research Peptide

Semax (10mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

Semax was developed by the Russian Academy of Sciences and has been in clinical use in Russia since the 1990s for stroke recovery, cognitive decline, and impaired attention. It is now one of the most-studied nootropic peptides globally.

The primary mechanism of research interest: Semax significantly upregulates BDNF (Brain-Derived Neurotrophic Factor), the neurotrophin involved in synaptic plasticity, memory consolidation, and neuronal survival. Increased BDNF expression is associated with stronger synaptic signalling and a more resilient neural environment in preclinical models.

Key Research Areas

• Attention & Processing Speed — Studied for improvements in attention, processing speed, and task performance under cognitive load
• Memory & Learning — BDNF upregulation studied for memory formation and recall
• Neuroprotection — Studied for protecting neurons from oxidative stress in stroke and cognitive decline models
• Stress Resilience — Associated with anxiolytic activity without sedation in preclinical models

Supplied as lyophilized powder at 99.349% purity as reported on the CoA, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.